Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Hormones significantly affect skin health, with vitamin D playing a key role.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that understanding dermal papilla cells is key to improving hair regeneration treatments.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Effective PCOS treatments require targeting specific signaling pathways.

Antiandrogen therapy helps treat genetic hair loss.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Hormones and genes affect hair growth and male baldness.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

PCOS is a major cause of infertility and requires personalized treatment.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.